R&D Magazine

Featured Headlines from the R&D Daily
Nanotube scale has sub-atom resolution
Squeezing light into tight spaces
Van Gogh’s hidden works are brought to life


Search R&D
 
Search Tips

SUBSCRIPTIONS

Magazine
   Digital
   Print
   Renew

The R&D Daily
   Recent Newsletters
   Subscribe
   Contact
   Advertise

Laboratory Design
   Newsletter Homepage
   Digital Edition
   Subscribe


FREE SUBSCRIPTIONS to R&D Magazine and Newsletters










Awards

R&D 100 Awards

Lab of the Year

Product Solutions

R&D e-Solutions

R&D Product Showcase


The ebbing tide of outrage?

The ebbing tide of outrage?
May 14, 2008

One easy way to measure the importance of a news story (or at least the importance the media places on the story) is to glance at the number of results hoarded by Google’s “News” search tool. I couldn’t say if this is an accurate metric—there are blog search tools out there that might be a better metric—but it does seem to reflect either public interest on a topic or the money involved.

I began watching this number more closely after seeing that a recent story in the UK’s Sunday Times about a genetically modified human embryo created in New York last year generated just 270 unique stories (or blogs or editorials as of this writing) on Google News after more than a day out in the open.

What gives? Though the researchers involved rightly used a non-viable embryo, and destroyed it after five days (presumably once their research goals were accomplished), the story generated little more outrage than could be mustered by a few conservative groups and perhaps the media itself.

I had expected a firestorm of controversy, but I guess we shouldn’t be surprised. The tide has turned. An administration hostile to this sort of stem cell R&D is wrapping up its term; California has already pledged $271 million to build stem cell facilities.

We could also find answers back at Google News. There are just too many competing news stories of note this week. Coverage of the Chengdu earthquake, for example, is approaching 3,000 significant stories (or blogs or editorials). The HP bid for EDS has taken over as the business story of the moment with nearly 2,000 articles.

There are literally dozens of stories that outrank the embryo revelations, including web gems—the secret UFO files in the UK recently released to the public—and obligatory hard news—Bush’s arrival in Israel for the celebration of the country’s 60-year anniversary.

I think everyone has realized that if the U.S. doesn’t get on board with this type of research, which looks both promising and profitable, someone somewhere else will be happy to give it a try.

E-mail the editor



E-mail for more information

E-mail to a colleague

Printer friendly format


   Show Archived Articles











Events Calendar

More Events



























Bioscience Technology Chromatography Techniques Drug Discovery & Development Laboratory Equipment Pharmaceutical Processing R&D Scientific Computing
Advantage Business Media © Copyright 2008 Advantage Business Media
Privacy Policy | Terms & Conditions | Advertise With Us